Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for AAGGCAC
Z-value: 1.25
Motif logo
miRNA associated with seed AAGGCAC
| Name | miRBASE accession |
|---|---|
|
hsa-miR-124-3p.1
|
MIMAT0000422 |
Activity profile of AAGGCAC motif
Sorted Z-values of AAGGCAC motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr4_-_149365827 | 7.04 |
ENST00000344721.4
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2 |
| chr21_+_36041688 | 4.52 |
ENST00000360731.3
ENST00000349499.2 |
CLIC6
|
chloride intracellular channel 6 |
| chr1_+_228870824 | 4.38 |
ENST00000366691.3
|
RHOU
|
ras homolog family member U |
| chr18_-_45663666 | 4.32 |
ENST00000535628.2
|
ZBTB7C
|
zinc finger and BTB domain containing 7C |
| chr6_-_90121938 | 4.08 |
ENST00000369415.4
|
RRAGD
|
Ras-related GTP binding D |
| chr19_+_709101 | 4.05 |
ENST00000338448.5
|
PALM
|
paralemmin |
| chr4_+_25657444 | 3.79 |
ENST00000504570.1
ENST00000382051.3 |
SLC34A2
|
solute carrier family 34 (type II sodium/phosphate contransporter), member 2 |
| chr14_+_67999999 | 3.67 |
ENST00000329153.5
|
PLEKHH1
|
pleckstrin homology domain containing, family H (with MyTH4 domain) member 1 |
| chr19_-_7990991 | 3.52 |
ENST00000318978.4
|
CTXN1
|
cortexin 1 |
| chr14_+_77648167 | 3.44 |
ENST00000554346.1
ENST00000298351.4 |
TMEM63C
|
transmembrane protein 63C |
| chr5_-_101632153 | 3.34 |
ENST00000310954.6
|
SLCO4C1
|
solute carrier organic anion transporter family, member 4C1 |
| chr17_+_68165657 | 3.15 |
ENST00000243457.3
|
KCNJ2
|
potassium inwardly-rectifying channel, subfamily J, member 2 |
| chr19_+_32896697 | 3.07 |
ENST00000586987.1
|
DPY19L3
|
dpy-19-like 3 (C. elegans) |
| chr15_+_45315302 | 3.07 |
ENST00000267814.9
|
SORD
|
sorbitol dehydrogenase |
| chr3_+_160473996 | 3.03 |
ENST00000498165.1
|
PPM1L
|
protein phosphatase, Mg2+/Mn2+ dependent, 1L |
| chr5_-_100238956 | 3.01 |
ENST00000231461.5
|
ST8SIA4
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 |
| chr15_-_49255632 | 2.95 |
ENST00000332408.4
|
SHC4
|
SHC (Src homology 2 domain containing) family, member 4 |
| chr13_-_86373536 | 2.94 |
ENST00000400286.2
|
SLITRK6
|
SLIT and NTRK-like family, member 6 |
| chr6_+_17281573 | 2.89 |
ENST00000379052.5
|
RBM24
|
RNA binding motif protein 24 |
| chr4_+_95679072 | 2.87 |
ENST00000515059.1
|
BMPR1B
|
bone morphogenetic protein receptor, type IB |
| chr7_+_121513143 | 2.81 |
ENST00000393386.2
|
PTPRZ1
|
protein tyrosine phosphatase, receptor-type, Z polypeptide 1 |
| chr9_-_89562104 | 2.81 |
ENST00000298743.7
|
GAS1
|
growth arrest-specific 1 |
| chr5_-_124080203 | 2.58 |
ENST00000504926.1
|
ZNF608
|
zinc finger protein 608 |
| chr19_-_14316980 | 2.57 |
ENST00000361434.3
ENST00000340736.6 |
LPHN1
|
latrophilin 1 |
| chr1_+_87794150 | 2.55 |
ENST00000370544.5
|
LMO4
|
LIM domain only 4 |
| chr6_-_134639180 | 2.51 |
ENST00000367858.5
|
SGK1
|
serum/glucocorticoid regulated kinase 1 |
| chr3_-_66551351 | 2.49 |
ENST00000273261.3
|
LRIG1
|
leucine-rich repeats and immunoglobulin-like domains 1 |
| chr12_-_89919965 | 2.48 |
ENST00000548729.1
|
POC1B-GALNT4
|
POC1B-GALNT4 readthrough |
| chr8_+_120885949 | 2.43 |
ENST00000523492.1
ENST00000286234.5 |
DEPTOR
|
DEP domain containing MTOR-interacting protein |
| chr1_+_57110972 | 2.41 |
ENST00000371244.4
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit |
| chr12_-_89918522 | 2.41 |
ENST00000529983.2
|
GALNT4
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 4 (GalNAc-T4) |
| chr5_-_16509101 | 2.36 |
ENST00000399793.2
|
FAM134B
|
family with sequence similarity 134, member B |
| chr13_+_24734844 | 2.36 |
ENST00000382108.3
|
SPATA13
|
spermatogenesis associated 13 |
| chr6_+_16129308 | 2.32 |
ENST00000356840.3
ENST00000349606.4 |
MYLIP
|
myosin regulatory light chain interacting protein |
| chr19_+_17581253 | 2.31 |
ENST00000252595.7
ENST00000598424.1 |
SLC27A1
|
solute carrier family 27 (fatty acid transporter), member 1 |
| chr6_+_135502466 | 2.29 |
ENST00000367814.4
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog |
| chr8_+_67976593 | 2.18 |
ENST00000262210.5
ENST00000412460.1 |
CSPP1
|
centrosome and spindle pole associated protein 1 |
| chr16_+_28303804 | 2.16 |
ENST00000341901.4
|
SBK1
|
SH3 domain binding kinase 1 |
| chr9_-_3525968 | 2.14 |
ENST00000382004.3
ENST00000302303.1 ENST00000449190.1 |
RFX3
|
regulatory factor X, 3 (influences HLA class II expression) |
| chr5_-_9546180 | 2.14 |
ENST00000382496.5
|
SEMA5A
|
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
| chr5_+_75699040 | 2.13 |
ENST00000274364.6
|
IQGAP2
|
IQ motif containing GTPase activating protein 2 |
| chr7_-_124405681 | 2.01 |
ENST00000303921.2
|
GPR37
|
G protein-coupled receptor 37 (endothelin receptor type B-like) |
| chr3_+_49449636 | 1.98 |
ENST00000273590.3
|
TCTA
|
T-cell leukemia translocation altered |
| chr20_+_51588873 | 1.97 |
ENST00000371497.5
|
TSHZ2
|
teashirt zinc finger homeobox 2 |
| chr1_+_61547894 | 1.95 |
ENST00000403491.3
|
NFIA
|
nuclear factor I/A |
| chr1_+_151483855 | 1.94 |
ENST00000427934.2
ENST00000271636.7 |
CGN
|
cingulin |
| chr20_-_32031680 | 1.93 |
ENST00000217381.2
|
SNTA1
|
syntrophin, alpha 1 |
| chr1_+_210406121 | 1.89 |
ENST00000367012.3
|
SERTAD4
|
SERTA domain containing 4 |
| chr1_-_204329013 | 1.89 |
ENST00000272203.3
ENST00000414478.1 |
PLEKHA6
|
pleckstrin homology domain containing, family A member 6 |
| chr10_+_72164135 | 1.75 |
ENST00000373218.4
|
EIF4EBP2
|
eukaryotic translation initiation factor 4E binding protein 2 |
| chr6_+_138483058 | 1.73 |
ENST00000251691.4
|
KIAA1244
|
KIAA1244 |
| chr1_+_114472222 | 1.72 |
ENST00000369558.1
ENST00000369561.4 |
HIPK1
|
homeodomain interacting protein kinase 1 |
| chr11_+_113930291 | 1.70 |
ENST00000335953.4
|
ZBTB16
|
zinc finger and BTB domain containing 16 |
| chr9_+_136325089 | 1.67 |
ENST00000291722.7
ENST00000316948.4 ENST00000540581.1 |
CACFD1
|
calcium channel flower domain containing 1 |
| chr6_-_154831779 | 1.67 |
ENST00000607772.1
|
CNKSR3
|
CNKSR family member 3 |
| chr12_+_93771659 | 1.66 |
ENST00000337179.5
ENST00000415493.2 |
NUDT4
|
nudix (nucleoside diphosphate linked moiety X)-type motif 4 |
| chr6_+_39760783 | 1.63 |
ENST00000398904.2
ENST00000538976.1 |
DAAM2
|
dishevelled associated activator of morphogenesis 2 |
| chr8_+_17354587 | 1.62 |
ENST00000494857.1
ENST00000522656.1 |
SLC7A2
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
| chr14_-_95786200 | 1.61 |
ENST00000298912.4
|
CLMN
|
calmin (calponin-like, transmembrane) |
| chr3_+_183353356 | 1.60 |
ENST00000242810.6
ENST00000493074.1 ENST00000437402.1 ENST00000454495.2 ENST00000473045.1 ENST00000468101.1 ENST00000427201.2 ENST00000482138.1 ENST00000454652.2 |
KLHL24
|
kelch-like family member 24 |
| chr4_+_41362796 | 1.60 |
ENST00000508501.1
ENST00000512946.1 ENST00000313860.7 ENST00000512632.1 ENST00000512820.1 |
LIMCH1
|
LIM and calponin homology domains 1 |
| chr9_-_139922631 | 1.59 |
ENST00000341511.6
|
ABCA2
|
ATP-binding cassette, sub-family A (ABC1), member 2 |
| chr11_-_95522907 | 1.58 |
ENST00000358780.5
ENST00000542135.1 |
FAM76B
|
family with sequence similarity 76, member B |
| chr9_-_20622478 | 1.58 |
ENST00000355930.6
ENST00000380338.4 |
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 |
| chr14_-_61190754 | 1.57 |
ENST00000216513.4
|
SIX4
|
SIX homeobox 4 |
| chr2_+_219536749 | 1.55 |
ENST00000295709.3
ENST00000392106.2 ENST00000392105.3 ENST00000455724.1 |
STK36
|
serine/threonine kinase 36 |
| chr18_-_30050395 | 1.54 |
ENST00000269209.6
ENST00000399218.4 |
GAREM
|
GRB2 associated, regulator of MAPK1 |
| chr16_-_68482440 | 1.52 |
ENST00000219334.5
|
SMPD3
|
sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) |
| chr16_+_69599861 | 1.52 |
ENST00000354436.2
|
NFAT5
|
nuclear factor of activated T-cells 5, tonicity-responsive |
| chr5_+_149340282 | 1.52 |
ENST00000286298.4
|
SLC26A2
|
solute carrier family 26 (anion exchanger), member 2 |
| chrX_-_132549506 | 1.51 |
ENST00000370828.3
|
GPC4
|
glypican 4 |
| chr5_+_127419449 | 1.50 |
ENST00000262461.2
ENST00000343225.4 |
SLC12A2
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 2 |
| chr2_-_216946500 | 1.50 |
ENST00000265322.7
|
PECR
|
peroxisomal trans-2-enoyl-CoA reductase |
| chr19_+_13135386 | 1.49 |
ENST00000360105.4
ENST00000588228.1 ENST00000591028.1 |
NFIX
|
nuclear factor I/X (CCAAT-binding transcription factor) |
| chr6_+_28109703 | 1.47 |
ENST00000457389.2
ENST00000330236.6 |
ZKSCAN8
|
zinc finger with KRAB and SCAN domains 8 |
| chr6_+_71998506 | 1.47 |
ENST00000370435.4
|
OGFRL1
|
opioid growth factor receptor-like 1 |
| chr2_+_231729615 | 1.46 |
ENST00000326427.6
ENST00000335005.6 ENST00000326407.6 |
ITM2C
|
integral membrane protein 2C |
| chr6_+_1312675 | 1.46 |
ENST00000296839.2
|
FOXQ1
|
forkhead box Q1 |
| chrX_-_112084043 | 1.45 |
ENST00000304758.1
|
AMOT
|
angiomotin |
| chr10_-_52383644 | 1.44 |
ENST00000361781.2
|
SGMS1
|
sphingomyelin synthase 1 |
| chr6_+_148663729 | 1.44 |
ENST00000367467.3
|
SASH1
|
SAM and SH3 domain containing 1 |
| chr12_+_124196865 | 1.43 |
ENST00000330342.3
|
ATP6V0A2
|
ATPase, H+ transporting, lysosomal V0 subunit a2 |
| chr22_+_25465786 | 1.42 |
ENST00000401395.1
|
KIAA1671
|
KIAA1671 |
| chr4_+_81951957 | 1.42 |
ENST00000282701.2
|
BMP3
|
bone morphogenetic protein 3 |
| chr8_-_29120580 | 1.41 |
ENST00000524189.1
|
KIF13B
|
kinesin family member 13B |
| chr1_-_1535455 | 1.41 |
ENST00000422725.1
|
C1orf233
|
chromosome 1 open reading frame 233 |
| chr2_+_54951679 | 1.40 |
ENST00000356458.6
|
EML6
|
echinoderm microtubule associated protein like 6 |
| chr3_+_69812877 | 1.40 |
ENST00000457080.1
ENST00000328528.6 |
MITF
|
microphthalmia-associated transcription factor |
| chr5_+_140254884 | 1.40 |
ENST00000398631.2
|
PCDHA12
|
protocadherin alpha 12 |
| chr5_+_140248518 | 1.40 |
ENST00000398640.2
|
PCDHA11
|
protocadherin alpha 11 |
| chr7_+_17338239 | 1.40 |
ENST00000242057.4
|
AHR
|
aryl hydrocarbon receptor |
| chr5_+_140213815 | 1.36 |
ENST00000525929.1
ENST00000378125.3 |
PCDHA7
|
protocadherin alpha 7 |
| chr19_-_33793430 | 1.35 |
ENST00000498907.2
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha |
| chr5_+_140227048 | 1.35 |
ENST00000532602.1
|
PCDHA9
|
protocadherin alpha 9 |
| chr7_+_89841000 | 1.34 |
ENST00000287908.3
|
STEAP2
|
STEAP family member 2, metalloreductase |
| chr5_-_133968529 | 1.34 |
ENST00000402673.2
|
SAR1B
|
SAR1 homolog B (S. cerevisiae) |
| chr7_+_3340989 | 1.34 |
ENST00000404826.2
ENST00000389531.3 |
SDK1
|
sidekick cell adhesion molecule 1 |
| chr6_+_143929307 | 1.31 |
ENST00000427704.2
ENST00000305766.6 |
PHACTR2
|
phosphatase and actin regulator 2 |
| chr5_+_140220769 | 1.31 |
ENST00000531613.1
ENST00000378123.3 |
PCDHA8
|
protocadherin alpha 8 |
| chr22_+_29279552 | 1.31 |
ENST00000544604.2
|
ZNRF3
|
zinc and ring finger 3 |
| chr17_+_29718642 | 1.30 |
ENST00000325874.8
|
RAB11FIP4
|
RAB11 family interacting protein 4 (class II) |
| chr6_-_154677900 | 1.29 |
ENST00000265198.4
ENST00000520261.1 |
IPCEF1
|
interaction protein for cytohesin exchange factors 1 |
| chr18_-_47721447 | 1.28 |
ENST00000285039.7
|
MYO5B
|
myosin VB |
| chr6_+_46097711 | 1.27 |
ENST00000321037.4
|
ENPP4
|
ectonucleotide pyrophosphatase/phosphodiesterase 4 (putative) |
| chr8_+_74206829 | 1.24 |
ENST00000240285.5
|
RDH10
|
retinol dehydrogenase 10 (all-trans) |
| chr17_+_53342311 | 1.24 |
ENST00000226067.5
|
HLF
|
hepatic leukemia factor |
| chr11_+_7597639 | 1.23 |
ENST00000533792.1
|
PPFIBP2
|
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
| chr2_+_11295498 | 1.23 |
ENST00000295083.3
ENST00000441908.2 |
PQLC3
|
PQ loop repeat containing 3 |
| chr18_-_53255766 | 1.21 |
ENST00000566286.1
ENST00000564999.1 ENST00000566279.1 ENST00000354452.3 ENST00000356073.4 |
TCF4
|
transcription factor 4 |
| chr11_+_61520075 | 1.21 |
ENST00000278836.5
|
MYRF
|
myelin regulatory factor |
| chr10_+_71211212 | 1.21 |
ENST00000373290.2
|
TSPAN15
|
tetraspanin 15 |
| chr5_+_56111361 | 1.21 |
ENST00000399503.3
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
| chr17_-_42200996 | 1.20 |
ENST00000587135.1
ENST00000225983.6 ENST00000393622.2 ENST00000588703.1 |
HDAC5
|
histone deacetylase 5 |
| chr12_-_65146636 | 1.18 |
ENST00000418919.2
|
GNS
|
glucosamine (N-acetyl)-6-sulfatase |
| chr5_+_153825510 | 1.18 |
ENST00000297109.6
|
SAP30L
|
SAP30-like |
| chr6_+_158957431 | 1.17 |
ENST00000367090.3
|
TMEM181
|
transmembrane protein 181 |
| chr2_+_85766280 | 1.16 |
ENST00000306434.3
|
MAT2A
|
methionine adenosyltransferase II, alpha |
| chr1_+_92495528 | 1.15 |
ENST00000370383.4
|
EPHX4
|
epoxide hydrolase 4 |
| chr17_-_202579 | 1.15 |
ENST00000577079.1
ENST00000331302.7 ENST00000536489.2 |
RPH3AL
|
rabphilin 3A-like (without C2 domains) |
| chr3_-_114790179 | 1.15 |
ENST00000462705.1
|
ZBTB20
|
zinc finger and BTB domain containing 20 |
| chr11_-_72853091 | 1.14 |
ENST00000311172.7
ENST00000409314.1 |
FCHSD2
|
FCH and double SH3 domains 2 |
| chr3_-_141868357 | 1.12 |
ENST00000489671.1
ENST00000475734.1 ENST00000467072.1 ENST00000499676.2 |
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2) |
| chr19_+_10527449 | 1.12 |
ENST00000592685.1
ENST00000380702.2 |
PDE4A
|
phosphodiesterase 4A, cAMP-specific |
| chr6_-_99395787 | 1.11 |
ENST00000369244.2
ENST00000229971.1 |
FBXL4
|
F-box and leucine-rich repeat protein 4 |
| chr4_+_129730779 | 1.10 |
ENST00000226319.6
|
PHF17
|
jade family PHD finger 1 |
| chr2_+_88991162 | 1.08 |
ENST00000283646.4
|
RPIA
|
ribose 5-phosphate isomerase A |
| chr9_+_22446814 | 1.07 |
ENST00000325870.2
|
DMRTA1
|
DMRT-like family A1 |
| chr12_-_118541743 | 1.07 |
ENST00000359236.5
|
VSIG10
|
V-set and immunoglobulin domain containing 10 |
| chr9_+_126773880 | 1.07 |
ENST00000373615.4
|
LHX2
|
LIM homeobox 2 |
| chr11_+_73019282 | 1.07 |
ENST00000263674.3
|
ARHGEF17
|
Rho guanine nucleotide exchange factor (GEF) 17 |
| chr1_+_116915855 | 1.06 |
ENST00000295598.5
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
| chr12_+_121148228 | 1.06 |
ENST00000344651.4
|
UNC119B
|
unc-119 homolog B (C. elegans) |
| chr1_-_169455169 | 1.06 |
ENST00000367804.4
ENST00000236137.5 |
SLC19A2
|
solute carrier family 19 (thiamine transporter), member 2 |
| chr17_+_7608511 | 1.05 |
ENST00000226091.2
|
EFNB3
|
ephrin-B3 |
| chr1_-_234614849 | 1.05 |
ENST00000040877.1
|
TARBP1
|
TAR (HIV-1) RNA binding protein 1 |
| chr2_+_172378757 | 1.05 |
ENST00000409484.1
ENST00000321348.4 ENST00000375252.3 |
CYBRD1
|
cytochrome b reductase 1 |
| chr4_+_7045042 | 1.05 |
ENST00000310074.7
ENST00000512388.1 |
TADA2B
|
transcriptional adaptor 2B |
| chr11_-_22851367 | 1.05 |
ENST00000354193.4
|
SVIP
|
small VCP/p97-interacting protein |
| chr5_+_172483347 | 1.03 |
ENST00000522692.1
ENST00000296953.2 ENST00000540014.1 ENST00000520420.1 |
CREBRF
|
CREB3 regulatory factor |
| chr11_-_118023490 | 1.02 |
ENST00000324727.4
|
SCN4B
|
sodium channel, voltage-gated, type IV, beta subunit |
| chr12_-_15942309 | 1.02 |
ENST00000544064.1
ENST00000543523.1 ENST00000536793.1 |
EPS8
|
epidermal growth factor receptor pathway substrate 8 |
| chr12_+_52445191 | 1.01 |
ENST00000243050.1
ENST00000394825.1 ENST00000550763.1 ENST00000394824.2 ENST00000548232.1 ENST00000562373.1 |
NR4A1
|
nuclear receptor subfamily 4, group A, member 1 |
| chr4_-_170192185 | 1.01 |
ENST00000284637.9
|
SH3RF1
|
SH3 domain containing ring finger 1 |
| chr8_+_143808605 | 1.01 |
ENST00000336138.3
|
THEM6
|
thioesterase superfamily member 6 |
| chr6_+_167412665 | 1.00 |
ENST00000366847.4
|
FGFR1OP
|
FGFR1 oncogene partner |
| chr11_-_119252359 | 1.00 |
ENST00000455332.2
|
USP2
|
ubiquitin specific peptidase 2 |
| chr2_+_26915584 | 0.99 |
ENST00000302909.3
|
KCNK3
|
potassium channel, subfamily K, member 3 |
| chr21_-_34852304 | 0.99 |
ENST00000542230.2
|
TMEM50B
|
transmembrane protein 50B |
| chr7_-_112430647 | 0.98 |
ENST00000312814.6
|
TMEM168
|
transmembrane protein 168 |
| chr4_-_168155730 | 0.98 |
ENST00000502330.1
ENST00000357154.3 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
| chr13_+_88324870 | 0.97 |
ENST00000325089.6
|
SLITRK5
|
SLIT and NTRK-like family, member 5 |
| chr1_+_179050512 | 0.96 |
ENST00000367627.3
|
TOR3A
|
torsin family 3, member A |
| chr2_-_230933709 | 0.96 |
ENST00000436869.1
ENST00000295190.4 |
SLC16A14
|
solute carrier family 16, member 14 |
| chr16_+_4364762 | 0.96 |
ENST00000262366.3
|
GLIS2
|
GLIS family zinc finger 2 |
| chr8_+_110346546 | 0.95 |
ENST00000521662.1
ENST00000521688.1 ENST00000520147.1 |
ENY2
|
enhancer of yellow 2 homolog (Drosophila) |
| chr1_+_179923873 | 0.95 |
ENST00000367607.3
ENST00000491495.2 |
CEP350
|
centrosomal protein 350kDa |
| chr5_-_131826457 | 0.95 |
ENST00000437654.1
ENST00000245414.4 |
IRF1
|
interferon regulatory factor 1 |
| chr7_+_139026057 | 0.95 |
ENST00000541515.3
|
LUC7L2
|
LUC7-like 2 (S. cerevisiae) |
| chr1_+_201979645 | 0.94 |
ENST00000367284.5
ENST00000367283.3 |
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
| chrX_-_10645773 | 0.94 |
ENST00000453318.2
|
MID1
|
midline 1 (Opitz/BBB syndrome) |
| chr2_-_24149977 | 0.94 |
ENST00000238789.5
|
ATAD2B
|
ATPase family, AAA domain containing 2B |
| chr4_-_89619386 | 0.93 |
ENST00000323061.5
|
NAP1L5
|
nucleosome assembly protein 1-like 5 |
| chr2_-_86564776 | 0.93 |
ENST00000165698.5
ENST00000541910.1 ENST00000535845.1 |
REEP1
|
receptor accessory protein 1 |
| chr5_+_102201430 | 0.93 |
ENST00000438793.3
ENST00000346918.2 |
PAM
|
peptidylglycine alpha-amidating monooxygenase |
| chr2_-_96874553 | 0.92 |
ENST00000337288.5
ENST00000443962.1 |
STARD7
|
StAR-related lipid transfer (START) domain containing 7 |
| chr4_+_108745711 | 0.91 |
ENST00000394684.4
|
SGMS2
|
sphingomyelin synthase 2 |
| chr5_-_473135 | 0.91 |
ENST00000342584.3
|
CTD-2228K2.5
|
Uncharacterized protein |
| chr11_-_74109422 | 0.89 |
ENST00000298198.4
|
PGM2L1
|
phosphoglucomutase 2-like 1 |
| chr12_+_111843749 | 0.88 |
ENST00000341259.2
|
SH2B3
|
SH2B adaptor protein 3 |
| chr1_-_86174065 | 0.88 |
ENST00000370574.3
ENST00000431532.2 |
ZNHIT6
|
zinc finger, HIT-type containing 6 |
| chr20_-_18038521 | 0.88 |
ENST00000278780.6
|
OVOL2
|
ovo-like zinc finger 2 |
| chr2_-_97405775 | 0.86 |
ENST00000264963.4
ENST00000537039.1 ENST00000377079.4 ENST00000426463.2 ENST00000534882.1 |
LMAN2L
|
lectin, mannose-binding 2-like |
| chr20_-_45035223 | 0.86 |
ENST00000450812.1
ENST00000290246.6 ENST00000439931.2 ENST00000396391.1 |
ELMO2
|
engulfment and cell motility 2 |
| chr11_-_45687128 | 0.86 |
ENST00000308064.2
|
CHST1
|
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 |
| chr1_-_225840747 | 0.86 |
ENST00000366843.2
ENST00000366844.3 |
ENAH
|
enabled homolog (Drosophila) |
| chr5_+_131705438 | 0.85 |
ENST00000245407.3
|
SLC22A5
|
solute carrier family 22 (organic cation/carnitine transporter), member 5 |
| chr1_+_15943995 | 0.85 |
ENST00000480945.1
|
DDI2
|
DNA-damage inducible 1 homolog 2 (S. cerevisiae) |
| chr20_+_33292068 | 0.85 |
ENST00000374810.3
ENST00000374809.2 ENST00000451665.1 |
TP53INP2
|
tumor protein p53 inducible nuclear protein 2 |
| chr3_+_119187785 | 0.84 |
ENST00000295588.4
ENST00000476573.1 |
POGLUT1
|
protein O-glucosyltransferase 1 |
| chr19_-_3063099 | 0.84 |
ENST00000221561.8
|
AES
|
amino-terminal enhancer of split |
| chr12_+_48166978 | 0.84 |
ENST00000442218.2
|
SLC48A1
|
solute carrier family 48 (heme transporter), member 1 |
| chr1_+_101361626 | 0.83 |
ENST00000370112.4
|
SLC30A7
|
solute carrier family 30 (zinc transporter), member 7 |
| chr11_+_10471836 | 0.83 |
ENST00000444303.2
|
AMPD3
|
adenosine monophosphate deaminase 3 |
| chr3_+_29322803 | 0.83 |
ENST00000396583.3
ENST00000383767.2 |
RBMS3
|
RNA binding motif, single stranded interacting protein 3 |
| chr18_+_72922710 | 0.83 |
ENST00000322038.5
|
TSHZ1
|
teashirt zinc finger homeobox 1 |
| chr17_+_28705921 | 0.82 |
ENST00000225719.4
|
CPD
|
carboxypeptidase D |
| chr9_-_125675576 | 0.82 |
ENST00000373659.3
|
ZBTB6
|
zinc finger and BTB domain containing 6 |
| chr9_-_27573392 | 0.82 |
ENST00000380003.3
|
C9orf72
|
chromosome 9 open reading frame 72 |
| chr16_-_66730583 | 0.81 |
ENST00000330687.4
ENST00000394106.2 ENST00000563952.1 |
CMTM4
|
CKLF-like MARVEL transmembrane domain containing 4 |
| chr14_+_23067146 | 0.81 |
ENST00000428304.2
|
ABHD4
|
abhydrolase domain containing 4 |
| chr15_+_40763150 | 0.81 |
ENST00000306243.5
ENST00000559991.1 |
CHST14
|
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14 |
| chr8_+_95732095 | 0.81 |
ENST00000414645.2
|
DPY19L4
|
dpy-19-like 4 (C. elegans) |
| chr5_+_149109825 | 0.80 |
ENST00000360453.4
ENST00000394320.3 ENST00000309241.5 |
PPARGC1B
|
peroxisome proliferator-activated receptor gamma, coactivator 1 beta |
| chr9_-_80646374 | 0.80 |
ENST00000286548.4
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide |
| chr6_-_79787902 | 0.80 |
ENST00000275034.4
|
PHIP
|
pleckstrin homology domain interacting protein |
| chr9_+_104161123 | 0.80 |
ENST00000374861.3
ENST00000339664.2 ENST00000259395.4 |
ZNF189
|
zinc finger protein 189 |
| chr14_-_78083112 | 0.80 |
ENST00000216484.2
|
SPTLC2
|
serine palmitoyltransferase, long chain base subunit 2 |
| chr2_-_160472952 | 0.79 |
ENST00000541068.2
ENST00000355831.2 ENST00000343439.5 ENST00000392782.1 |
BAZ2B
|
bromodomain adjacent to zinc finger domain, 2B |
| chr6_+_133562472 | 0.79 |
ENST00000430974.2
ENST00000367895.5 ENST00000355167.3 ENST00000355286.6 |
EYA4
|
eyes absent homolog 4 (Drosophila) |
| chr7_+_140774032 | 0.79 |
ENST00000565468.1
|
TMEM178B
|
transmembrane protein 178B |
Network of associatons between targets according to the STRING database.
First level regulatory network of AAGGCAC
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.1 | 3.2 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
| 1.0 | 3.1 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 0.8 | 2.3 | GO:1990922 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.7 | 2.1 | GO:0072560 | glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) |
| 0.6 | 2.9 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.5 | 1.6 | GO:1903410 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
| 0.5 | 1.6 | GO:1902725 | negative regulation of satellite cell differentiation(GO:1902725) |
| 0.5 | 4.1 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 0.5 | 4.0 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.5 | 1.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.5 | 2.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.5 | 2.9 | GO:0060005 | vestibular reflex(GO:0060005) |
| 0.5 | 3.9 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.5 | 1.4 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.4 | 1.2 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.4 | 3.8 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.4 | 3.0 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.3 | 0.7 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 0.3 | 1.7 | GO:0051138 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) positive regulation of NK T cell differentiation(GO:0051138) germline stem cell asymmetric division(GO:0098728) |
| 0.3 | 2.3 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.3 | 0.3 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 0.3 | 1.6 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.3 | 1.5 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.3 | 4.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.3 | 1.8 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.3 | 1.8 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
| 0.3 | 3.0 | GO:0015677 | copper ion import(GO:0015677) |
| 0.3 | 1.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.3 | 1.4 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 0.3 | 1.7 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
| 0.3 | 2.5 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.3 | 0.5 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.3 | 1.6 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.3 | 1.1 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.3 | 0.3 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
| 0.3 | 1.3 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.3 | 1.5 | GO:1901907 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.2 | 2.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.2 | 0.7 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
| 0.2 | 0.9 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 0.2 | 0.7 | GO:1902769 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
| 0.2 | 0.9 | GO:0018032 | protein amidation(GO:0018032) |
| 0.2 | 3.2 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.2 | 4.0 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
| 0.2 | 0.6 | GO:0032506 | cytokinetic process(GO:0032506) |
| 0.2 | 0.8 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.2 | 1.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.2 | 3.0 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
| 0.2 | 0.6 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.2 | 2.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.2 | 0.6 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.2 | 1.0 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.2 | 0.8 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 0.2 | 0.6 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.2 | 1.5 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.2 | 1.1 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.2 | 0.8 | GO:0060023 | soft palate development(GO:0060023) |
| 0.2 | 1.2 | GO:0060431 | primary lung bud formation(GO:0060431) |
| 0.2 | 1.2 | GO:0032439 | endosome localization(GO:0032439) |
| 0.2 | 1.1 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.2 | 0.5 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.2 | 1.1 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of steroid hormone biosynthetic process(GO:0090032) |
| 0.2 | 0.6 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.1 | 0.6 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
| 0.1 | 0.7 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.1 | 0.6 | GO:0006850 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.1 | 0.3 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.1 | 1.6 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.1 | 1.8 | GO:0071560 | response to transforming growth factor beta(GO:0071559) cellular response to transforming growth factor beta stimulus(GO:0071560) |
| 0.1 | 0.8 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.1 | 1.8 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.1 | 0.4 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
| 0.1 | 1.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.1 | 2.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.1 | 1.1 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.1 | 2.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.1 | 1.3 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.1 | 1.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.1 | 1.3 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.1 | 0.5 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.1 | 0.4 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.1 | 0.5 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
| 0.1 | 0.6 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.1 | 1.0 | GO:0061469 | response to corticotropin-releasing hormone(GO:0043435) regulation of type B pancreatic cell proliferation(GO:0061469) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.1 | 0.4 | GO:0034059 | response to anoxia(GO:0034059) |
| 0.1 | 0.4 | GO:0060061 | Spemann organizer formation(GO:0060061) |
| 0.1 | 0.9 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.1 | 1.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.1 | 0.6 | GO:0060214 | endocardium formation(GO:0060214) |
| 0.1 | 1.3 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.1 | 0.5 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 | 0.5 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 0.1 | 0.4 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.1 | 1.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
| 0.1 | 1.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.1 | 1.7 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.1 | 0.8 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 | 0.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.1 | 0.3 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.1 | 0.6 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.1 | 0.3 | GO:1901143 | insulin catabolic process(GO:1901143) |
| 0.1 | 0.3 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.1 | 0.2 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.1 | 1.7 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
| 0.1 | 0.3 | GO:1902616 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.1 | 0.3 | GO:1902683 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) regulation of receptor localization to synapse(GO:1902683) |
| 0.1 | 0.5 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.1 | 1.3 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
| 0.1 | 0.7 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.1 | 0.3 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
| 0.1 | 0.3 | GO:0036446 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 0.1 | 0.6 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 0.1 | 0.3 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.1 | 0.1 | GO:0098907 | regulation of SA node cell action potential(GO:0098907) |
| 0.1 | 0.3 | GO:1990569 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.1 | 2.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.1 | 1.6 | GO:0007379 | segment specification(GO:0007379) |
| 0.1 | 0.3 | GO:0035284 | rhombomere 3 development(GO:0021569) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.1 | 1.0 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.1 | 0.8 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.1 | 0.5 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
| 0.1 | 1.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 0.1 | 0.8 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
| 0.1 | 1.8 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.1 | 1.5 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
| 0.1 | 0.8 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.1 | 0.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.1 | 0.6 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.1 | 1.2 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.1 | 0.2 | GO:0060139 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.1 | 0.5 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.1 | 0.3 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.1 | 0.6 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.1 | 0.3 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.1 | 0.4 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.1 | 0.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.1 | 0.6 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
| 0.1 | 0.9 | GO:0060326 | cell chemotaxis(GO:0060326) |
| 0.1 | 0.9 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
| 0.1 | 2.7 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) |
| 0.1 | 1.6 | GO:0072189 | ureter development(GO:0072189) |
| 0.1 | 0.8 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.1 | 1.6 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 | 1.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.1 | 0.3 | GO:0043622 | cortical microtubule organization(GO:0043622) establishment of centrosome localization(GO:0051660) |
| 0.1 | 0.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.1 | 1.2 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
| 0.1 | 0.5 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 0.1 | 0.8 | GO:0015886 | heme transport(GO:0015886) |
| 0.1 | 0.3 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.1 | 0.3 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 0.1 | 1.4 | GO:0031167 | rRNA methylation(GO:0031167) |
| 0.1 | 0.3 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
| 0.1 | 0.3 | GO:0044856 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 0.1 | 0.1 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.1 | 1.3 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.1 | 0.3 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 0.1 | 0.1 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 | 0.7 | GO:0001553 | luteinization(GO:0001553) |
| 0.1 | 0.4 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.1 | 0.2 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 0.1 | 3.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.1 | 0.2 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.1 | 0.2 | GO:0032898 | nerve growth factor processing(GO:0032455) neurotrophin production(GO:0032898) |
| 0.1 | 0.7 | GO:0038203 | TORC2 signaling(GO:0038203) negative regulation of TORC1 signaling(GO:1904262) |
| 0.1 | 0.4 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.1 | 0.5 | GO:0072520 | seminiferous tubule development(GO:0072520) |
| 0.1 | 0.6 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.1 | 1.9 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
| 0.1 | 0.5 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.1 | 0.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.1 | 0.4 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
| 0.1 | 1.3 | GO:0007625 | grooming behavior(GO:0007625) |
| 0.1 | 0.2 | GO:0090212 | vitamin E metabolic process(GO:0042360) regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.1 | 0.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.1 | 0.3 | GO:0034670 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 0.1 | 0.8 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.1 | 1.5 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
| 0.0 | 0.1 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 0.0 | 5.2 | GO:0006749 | glutathione metabolic process(GO:0006749) |
| 0.0 | 8.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 | 2.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 | 0.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.0 | 0.6 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.0 | 0.2 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.0 | 1.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 | 0.5 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 0.0 | 0.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.0 | 0.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 0.0 | 1.0 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 | 0.5 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.0 | 0.5 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.0 | 2.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
| 0.0 | 0.1 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
| 0.0 | 2.7 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.0 | 0.1 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
| 0.0 | 0.4 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.0 | 0.4 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.0 | 0.2 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
| 0.0 | 0.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.0 | 1.2 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
| 0.0 | 1.6 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.0 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 0.0 | 0.4 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.0 | 0.2 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
| 0.0 | 0.3 | GO:2000794 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.0 | 0.7 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.0 | 0.1 | GO:0051806 | entry into host cell(GO:0030260) entry of bacterium into host cell(GO:0035635) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
| 0.0 | 0.8 | GO:0060761 | negative regulation of response to cytokine stimulus(GO:0060761) |
| 0.0 | 0.3 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.0 | 0.7 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.0 | 0.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.0 | 0.1 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
| 0.0 | 0.5 | GO:0042113 | B cell activation(GO:0042113) |
| 0.0 | 0.1 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 0.0 | 0.2 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
| 0.0 | 0.4 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.0 | 1.1 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 | 0.3 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
| 0.0 | 0.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.0 | 0.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.0 | 0.1 | GO:0043323 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.0 | 0.0 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.0 | 0.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.0 | 0.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.0 | 0.3 | GO:0032526 | response to retinoic acid(GO:0032526) |
| 0.0 | 0.1 | GO:0031050 | dsRNA fragmentation(GO:0031050) production of small RNA involved in gene silencing by RNA(GO:0070918) |
| 0.0 | 0.4 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
| 0.0 | 0.7 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.0 | 0.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.0 | 0.2 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 0.0 | 0.3 | GO:0003360 | brainstem development(GO:0003360) |
| 0.0 | 0.3 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
| 0.0 | 0.2 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.0 | 1.2 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.0 | 0.1 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 0.0 | 0.8 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.0 | 0.5 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.0 | 0.5 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
| 0.0 | 0.1 | GO:0032926 | regulation of activin receptor signaling pathway(GO:0032925) negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.0 | 0.1 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 0.0 | 2.4 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.0 | 0.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 | 1.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.0 | 0.1 | GO:0097359 | UDP-glucosylation(GO:0097359) |
| 0.0 | 1.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.0 | 0.1 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.0 | 1.2 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.0 | 1.7 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
| 0.0 | 0.1 | GO:0060166 | olfactory pit development(GO:0060166) |
| 0.0 | 0.4 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
| 0.0 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) activation of meiosis(GO:0090427) |
| 0.0 | 0.2 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.0 | 0.2 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.0 | 1.3 | GO:0003407 | neural retina development(GO:0003407) |
| 0.0 | 0.3 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.0 | 0.3 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) |
| 0.0 | 0.3 | GO:0090278 | negative regulation of peptide secretion(GO:0002792) negative regulation of insulin secretion(GO:0046676) negative regulation of peptide hormone secretion(GO:0090278) |
| 0.0 | 0.3 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
| 0.0 | 1.1 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.0 | 0.5 | GO:0042755 | eating behavior(GO:0042755) |
| 0.0 | 0.4 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
| 0.0 | 0.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.0 | 0.1 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.0 | 0.5 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.0 | 0.6 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.0 | 0.0 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.0 | 0.6 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
| 0.0 | 0.2 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.0 | 0.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 | 0.2 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
| 0.0 | 0.3 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
| 0.0 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.0 | 1.4 | GO:0032760 | positive regulation of tumor necrosis factor production(GO:0032760) |
| 0.0 | 0.2 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.0 | 0.2 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
| 0.0 | 0.1 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
| 0.0 | 0.1 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.0 | 0.5 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.0 | 0.5 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.0 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
| 0.0 | 0.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.0 | 0.7 | GO:0097352 | autophagosome maturation(GO:0097352) |
| 0.0 | 0.3 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.0 | 0.4 | GO:0015695 | organic cation transport(GO:0015695) |
| 0.0 | 0.9 | GO:0061718 | NADH regeneration(GO:0006735) glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.0 | 0.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.0 | 0.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.0 | 0.6 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
| 0.0 | 0.3 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
| 0.0 | 0.4 | GO:0001893 | maternal placenta development(GO:0001893) |
| 0.0 | 0.1 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.0 | 0.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.0 | 0.7 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 | 0.1 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.0 | 0.3 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.0 | 0.0 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.0 | 0.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.0 | 0.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.0 | 0.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.0 | 0.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.0 | 0.2 | GO:1903432 | regulation of TORC1 signaling(GO:1903432) |
| 0.0 | 0.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 | 0.1 | GO:0051170 | nuclear import(GO:0051170) |
| 0.0 | 0.6 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.0 | 0.0 | GO:1904798 | mesodermal cell fate determination(GO:0007500) regulation of muscle hyperplasia(GO:0014738) negative regulation of muscle hyperplasia(GO:0014740) regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
| 0.0 | 0.5 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.0 | 0.3 | GO:0009299 | mRNA transcription(GO:0009299) |
| 0.0 | 0.5 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
| 0.0 | 0.2 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.0 | 0.2 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
| 0.0 | 0.1 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.0 | 0.0 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.0 | 1.1 | GO:0007588 | excretion(GO:0007588) |
| 0.0 | 0.2 | GO:0008643 | carbohydrate transport(GO:0008643) |
| 0.0 | 0.0 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.0 | 0.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 | 1.5 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.0 | 2.6 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.0 | 0.6 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.0 | 0.3 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.0 | 0.4 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
| 0.0 | 0.3 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 0.0 | 0.3 | GO:0016485 | protein processing(GO:0016485) |
| 0.0 | 0.0 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.0 | 0.9 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.9 | 2.8 | GO:0072534 | perineuronal net(GO:0072534) |
| 0.8 | 2.5 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.7 | 4.1 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.4 | 1.2 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.3 | 1.4 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.3 | 3.5 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.3 | 0.8 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.2 | 1.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 0.2 | 1.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.2 | 3.8 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.2 | 1.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.1 | 1.5 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.1 | 1.0 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.1 | 0.5 | GO:0060187 | cell pole(GO:0060187) |
| 0.1 | 0.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.1 | 0.4 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.1 | 1.6 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.1 | 0.5 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.1 | 1.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.1 | 1.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.1 | 0.5 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.1 | 1.3 | GO:0045179 | apical cortex(GO:0045179) |
| 0.1 | 0.9 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.1 | 0.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.1 | 2.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.1 | 0.6 | GO:0089701 | U2AF(GO:0089701) |
| 0.1 | 0.7 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.1 | 0.2 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 0.1 | 1.1 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.1 | 0.7 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.1 | 0.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.1 | 0.5 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
| 0.1 | 3.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.1 | 0.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.1 | 0.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.1 | 0.7 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
| 0.1 | 0.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.1 | 0.3 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
| 0.1 | 4.8 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.1 | 0.5 | GO:0033503 | HULC complex(GO:0033503) |
| 0.1 | 0.1 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
| 0.1 | 0.5 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.1 | 0.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.1 | 2.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.1 | 0.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.1 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.1 | 0.7 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.1 | 1.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.1 | 1.1 | GO:0090543 | Flemming body(GO:0090543) |
| 0.1 | 0.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.1 | 0.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.1 | 0.3 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
| 0.1 | 5.3 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.1 | 1.2 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.1 | 1.2 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.1 | 3.1 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.1 | 0.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.1 | 0.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.0 | 0.2 | GO:0032279 | axonemal microtubule(GO:0005879) asymmetric synapse(GO:0032279) |
| 0.0 | 1.4 | GO:0032991 | macromolecular complex(GO:0032991) |
| 0.0 | 0.3 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.0 | 0.3 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 0.0 | 0.7 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.0 | 0.8 | GO:0001741 | XY body(GO:0001741) |
| 0.0 | 1.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.0 | 0.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.0 | 0.2 | GO:0016939 | kinesin II complex(GO:0016939) |
| 0.0 | 0.2 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.0 | 0.5 | GO:0044754 | autolysosome(GO:0044754) |
| 0.0 | 1.1 | GO:0031968 | mitochondrial outer membrane(GO:0005741) outer membrane(GO:0019867) organelle outer membrane(GO:0031968) |
| 0.0 | 5.6 | GO:0016605 | PML body(GO:0016605) |
| 0.0 | 0.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.0 | 1.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.0 | 0.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.0 | 0.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
| 0.0 | 0.3 | GO:0072487 | MSL complex(GO:0072487) |
| 0.0 | 0.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.0 | 0.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.0 | 0.1 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.0 | 2.5 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.0 | 0.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.0 | 0.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.0 | 0.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.0 | 2.2 | GO:0043235 | receptor complex(GO:0043235) |
| 0.0 | 1.1 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.0 | 0.7 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.0 | 0.1 | GO:0031251 | PAN complex(GO:0031251) |
| 0.0 | 0.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.0 | 1.8 | GO:0002102 | podosome(GO:0002102) |
| 0.0 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.0 | 1.1 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.0 | 1.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.0 | 0.1 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
| 0.0 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.0 | 0.8 | GO:0030057 | desmosome(GO:0030057) |
| 0.0 | 0.4 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.0 | 0.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.0 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.0 | 1.9 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.0 | 0.7 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
| 0.0 | 0.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.0 | 0.2 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 0.0 | 0.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.0 | 1.1 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.0 | 0.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.0 | 0.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.0 | 0.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.0 | 2.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.0 | 0.1 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.0 | 0.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.0 | 0.5 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.0 | 0.3 | GO:0005605 | basal lamina(GO:0005605) |
| 0.0 | 0.4 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
| 0.0 | 1.6 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.0 | 1.6 | GO:0005884 | actin filament(GO:0005884) |
| 0.0 | 0.3 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 0.0 | 0.6 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
| 0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.0 | 0.2 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.0 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.0 | 0.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.0 | 0.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.0 | 0.8 | GO:0034774 | secretory granule lumen(GO:0034774) |
| 0.0 | 0.2 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.0 | 1.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.0 | 0.7 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
| 0.0 | 0.2 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 0.0 | 2.5 | GO:0031514 | motile cilium(GO:0031514) |
| 0.0 | 1.9 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.0 | 0.4 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
| 0.0 | 0.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.0 | 0.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.0 | 0.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.0 | 0.0 | GO:0071159 | NF-kappaB complex(GO:0071159) |
| 0.0 | 0.9 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.0 | 0.8 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.0 | 1.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.0 | 0.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.0 | 0.2 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 4.0 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 0.8 | 2.4 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 0.5 | 2.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.5 | 1.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 0.5 | 2.4 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.4 | 1.3 | GO:0090541 | MIT domain binding(GO:0090541) |
| 0.4 | 1.6 | GO:0005289 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
| 0.4 | 3.8 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
| 0.4 | 1.1 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
| 0.4 | 1.1 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 0.4 | 2.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.3 | 1.4 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.3 | 0.3 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
| 0.3 | 1.6 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.3 | 2.9 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.3 | 1.5 | GO:0052845 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.3 | 1.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.2 | 1.5 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.2 | 1.6 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.2 | 1.2 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
| 0.2 | 0.9 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.2 | 0.9 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
| 0.2 | 2.0 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
| 0.2 | 0.6 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
| 0.2 | 0.9 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 0.2 | 0.6 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 0.2 | 0.6 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 0.2 | 1.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.2 | 2.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.2 | 2.3 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.2 | 0.4 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
| 0.2 | 0.5 | GO:0032427 | GBD domain binding(GO:0032427) |
| 0.2 | 5.0 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.2 | 1.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
| 0.2 | 0.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
| 0.2 | 0.5 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.2 | 0.7 | GO:0043398 | HLH domain binding(GO:0043398) |
| 0.2 | 3.2 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
| 0.2 | 2.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.1 | 0.6 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.1 | 0.4 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
| 0.1 | 2.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.1 | 0.7 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
| 0.1 | 0.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.1 | 0.8 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 0.1 | 0.7 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.1 | 1.5 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 0.6 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.1 | 0.9 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.1 | 1.6 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
| 0.1 | 0.8 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.1 | 1.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.1 | 0.8 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.1 | 0.8 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.1 | 1.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.1 | 2.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.1 | 0.7 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.1 | 0.5 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
| 0.1 | 0.3 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 0.1 | 1.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.1 | 0.3 | GO:0098626 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
| 0.1 | 0.3 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.1 | 0.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.1 | 0.8 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.1 | 2.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.1 | 0.4 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.1 | 1.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.1 | 0.8 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.1 | 0.3 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
| 0.1 | 0.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.1 | 1.2 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.1 | 1.3 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.1 | 1.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.1 | 0.8 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.1 | 5.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.1 | 0.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
| 0.1 | 0.3 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.1 | 0.4 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
| 0.1 | 0.6 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.1 | 0.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 0.1 | 0.3 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
| 0.1 | 0.3 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
| 0.1 | 0.8 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.1 | 0.2 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 0.1 | 0.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.1 | 2.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.1 | 0.6 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.1 | 3.0 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.1 | 0.3 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.1 | 1.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.1 | 1.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.1 | 1.2 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.1 | 1.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.1 | 0.5 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
| 0.1 | 4.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.1 | 0.7 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.1 | 0.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.1 | 0.9 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.1 | 0.9 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.1 | 0.3 | GO:0003713 | transcription coactivator activity(GO:0003713) |
| 0.1 | 0.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.1 | 0.2 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.1 | 0.9 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.1 | 0.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.1 | 0.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.1 | 1.5 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.1 | 0.3 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.1 | 1.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.1 | 0.3 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
| 0.1 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.0 | 0.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.0 | 0.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.0 | 0.5 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.0 | 5.7 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.0 | 0.3 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.0 | 0.6 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.0 | 0.3 | GO:0043559 | insulin binding(GO:0043559) |
| 0.0 | 0.3 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 0.0 | 0.8 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.0 | 0.2 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
| 0.0 | 0.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.0 | 0.4 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.0 | 0.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.0 | 1.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.0 | 0.0 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.0 | 0.2 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 0.0 | 0.5 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.0 | 0.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.0 | 0.1 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
| 0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.0 | 2.1 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.0 | 2.7 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.0 | 1.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.0 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.0 | 0.2 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 0.0 | 0.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.0 | 0.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.0 | 0.3 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 0.0 | 0.1 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
| 0.0 | 1.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.0 | 1.1 | GO:0070888 | E-box binding(GO:0070888) |
| 0.0 | 0.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.0 | 0.5 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.0 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.0 | 0.3 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.0 | 1.3 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.0 | 0.3 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
| 0.0 | 1.8 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.0 | 0.4 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.0 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.0 | 0.4 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
| 0.0 | 0.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.0 | 0.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.0 | 2.5 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
| 0.0 | 0.4 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.0 | 0.2 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
| 0.0 | 0.9 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
| 0.0 | 0.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.0 | 0.1 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.0 | 0.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.0 | 0.7 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
| 0.0 | 0.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.0 | 0.1 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.0 | 0.5 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.0 | 0.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.0 | 0.1 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.0 | 2.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.0 | 0.1 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
| 0.0 | 3.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.0 | 0.6 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.0 | 0.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.0 | 0.3 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.0 | 0.3 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.0 | 2.3 | GO:0051287 | NAD binding(GO:0051287) |
| 0.0 | 0.6 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
| 0.0 | 0.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.0 | 0.5 | GO:0005537 | mannose binding(GO:0005537) |
| 0.0 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.0 | 0.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.0 | 0.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.0 | 0.4 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.0 | 2.7 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 0.0 | 0.4 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 0.0 | 0.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.0 | 1.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.0 | 0.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.0 | 0.9 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.0 | 0.6 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
| 0.0 | 1.3 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.0 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.0 | 0.2 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.0 | 0.2 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.0 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.0 | 0.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.0 | 0.2 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.0 | 3.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.0 | 0.2 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.0 | 0.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.0 | 0.2 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.0 | 0.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 0.0 | 1.1 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.0 | 0.4 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.0 | 0.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.0 | 0.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.0 | 0.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.0 | 0.1 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.0 | 0.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.0 | 0.3 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
| 0.0 | 0.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.0 | 0.1 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
| 0.0 | 0.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.0 | 0.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.0 | 0.7 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.0 | 0.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.0 | 0.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.0 | 0.6 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.0 | 0.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.0 | 0.0 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 0.0 | 0.1 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.0 | 0.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.0 | 1.3 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
| 0.0 | 0.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.0 | 3.7 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
| 0.0 | 0.2 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.0 | 0.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.0 | 0.7 | GO:0043621 | protein self-association(GO:0043621) |
| 0.0 | 0.2 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.0 | 0.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.0 | 0.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.0 | 0.7 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.0 | 0.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.0 | 0.7 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.3 | 0.9 | PID EPO PATHWAY | EPO signaling pathway |
| 0.1 | 1.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.1 | 2.9 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.1 | 1.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.1 | 7.1 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.1 | 2.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.1 | 4.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.1 | 2.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 3.0 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.0 | 0.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.0 | 1.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.0 | 2.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.0 | 1.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.0 | 3.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.0 | 2.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.0 | 0.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.0 | 1.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.0 | 0.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.0 | 0.6 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.0 | 0.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.0 | 2.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 1.5 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.0 | 0.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.0 | 0.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.0 | 0.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.0 | 1.1 | PID E2F PATHWAY | E2F transcription factor network |
| 0.0 | 1.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.0 | 1.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 1.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.0 | 1.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.0 | 0.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.0 | 0.9 | PID BMP PATHWAY | BMP receptor signaling |
| 0.0 | 1.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.0 | 0.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.0 | 0.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.0 | 0.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.0 | 0.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.2 | 2.5 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
| 0.2 | 3.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.1 | 4.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.1 | 1.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.1 | 0.3 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
| 0.1 | 1.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.1 | 2.0 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.1 | 0.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.1 | 2.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.1 | 2.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.1 | 1.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.1 | 1.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.1 | 0.9 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.1 | 2.9 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
| 0.1 | 0.3 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.1 | 1.6 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.1 | 1.3 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
| 0.1 | 4.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.0 | 2.0 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.0 | 7.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.0 | 0.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.0 | 1.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.0 | 1.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
| 0.0 | 1.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.0 | 0.7 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
| 0.0 | 1.4 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
| 0.0 | 2.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.0 | 0.4 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.0 | 0.6 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.0 | 0.5 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.0 | 0.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.0 | 0.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.0 | 0.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.0 | 0.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.0 | 0.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.0 | 1.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.0 | 1.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.0 | 2.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.0 | 0.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.0 | 1.9 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.0 | 1.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.0 | 1.9 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
| 0.0 | 0.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.0 | 1.2 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
| 0.0 | 0.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.0 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.0 | 1.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.0 | 0.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.0 | 0.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.0 | 0.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.0 | 0.2 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 0.0 | 0.9 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.0 | 0.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
| 0.0 | 0.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.0 | 0.4 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.0 | 0.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.0 | 0.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 0.0 | 0.4 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
| 0.0 | 0.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.0 | 0.1 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
| 0.0 | 1.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 0.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.0 | 0.2 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
| 0.0 | 0.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |